OUR MISSION:
To partner with healthcare providers, payers, patients and advocacy groups to eradicate colorectal cancer.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

CologuardĀ® Receives Coverage by Several Commercial Health Plans in Q1 2015

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced expanded patient access to Cologuard as a result of several insurers now covering the test. Cologuard is now covered for more than 90 million Medicare and commercial lives across the U.S. Since the start of 2015, several insurers began covering Cologuard as a noninvasive colon cancer screening...Read more

Employee Q&A: Air Support In Our Fight Against Cancer

Exact Sciences is recruiting heavily in an effort support the launch of Cologuard and development of our product pipeline. To support this effort, we'll be publishing Q&As with Exact team members in the areas we are hiring. This interview features Mike Maus, a Market Development Representative. As part of his role on our inside sales team, Mike supports our field sales organization by...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More